ERIS LIFESCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 907.6 INR | +1.16% |
|
+6.66% | -0.33% |
| 02:03pm | Eris Lifesciences Gets Board Nod to Raise Up to INR12.50 Billion Via Bond Sale | MT |
| Apr. 03 | Eris Lifesciences Completes Acquisition of Biocon Biologics' India Formulation Business | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 705B | ||||||
| 583B | ||||||
| 364B | ||||||
| 332B | ||||||
| 291B |
